Labbieux
The Labbieux Journal

Journal

Research updates, clinical context and considered perspectives for professionals working across regenerative science, peptide research and longevity.

Journal articles are published in English.

Lead story
Personalised peptide vaccine workflow from tumour mutation analysis to T-cell recognition
Clinical02 Aug 2026

Oncopept: Russia’s First Personalised Peptide Cancer Vaccine Enters Clinical Use

Oncopept has moved a patient-specific tumour-to-peptide workflow into clinical use in Russia. Explore how the platform works, the research supporting it and the cohort evidence that can define its precision-oncology potential.

Read the full story